Secondary analysis (6–7-year follow-up) of the hPOD trial in 1067 at-risk late preterm and term infants: prophylactic dextrose gel vs placebo did not reduce neurocognitive impairment (59% vs 57%; aRD 3%). Exploratory: more emotional-behavioural difficulty (24% vs 18%).
Secondary analysisn = 1,067
Harding et al. Prophylactic Dextrose Gel for Neonatal Hypoglycemia and Neurocognitive Function at 6 to 7 Years of Age: A Secondary Analysis of a Randomized Clinical Trial